Investment Trusts
The latest news, updates and opinions on Investment Trusts from the expert team here at MoneyWeek
Latest
-
A new beginning for the Rockwood Strategic investment trust
Tips Rockwood Strategic investment trust has been making positive changes, says Max King. Investors should tune in.
By Max King Published
-
-
Law Debenture investment trust update: premium over net assets slips
News Saloni Sardana looks at the latest update from the Law Debenture investment trust, one of the six funds in MoneyWeek’s model investment trust portfolio.
By Saloni Sardana Last updated
-
A family-run investment trust to buy and lock away
Tips Menhaden Resource Efficiency made a slow start, but progress is encouraging. Buy before the discount closes, says Max King.
By Max King Published
-
RIT Capital Partners update: discount to NAV narrows
News RIT Capital Partners one of the components of the MoneyWeek investment trust portfolio, has seen a narrowing in its share price's discount to its net asset value.
By Saloni Sardana Last updated
-
Caledonia Investments update: weak pound boosts returns
News Caledonia Investments, one of the components of the MoneyWeek investment trust portfolio, saw the value of its investments rise in April.
By Saloni Sardana Last updated
-
This specialist software fund is still cheap
Tips HgCapital Trust’s portfolio looks expensive, but its strong record should reassure investors, says Max King.
By Max King Published
-
Seven funds to shield your portfolio from inflation and rising interest rates
Tips With prices and interest rates on the rise, it's tough being an investor. But there are options to help ride out the storm. Rupert Hargreaves picks seven funds that should provide protection for your portfolio.
By Rupert Hargreaves Published
-
Scottish Mortgage Investment Trust update: discount to net asset value narrows
News Scottish Mortgage Investment Trust's is still trading at a discount relative to its net asset value – but the discount is narrowing, says Saloni Sardana.
By Saloni Sardana Last updated
-
Three healthcare trusts to invest in
Analysis The biotech sector is in its biggest bear market in 30 years. But Max King explains why this sector could turn around soon and three healthcare trusts that may be worth investing in.
By Max King Published